This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Pittsburgh. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pittsburgh, PA (US) (2021)
- Philadelphia, PA (US) (2023)
Company Filing History:
Years Active: 2021-2023
Title: Innovations by John Milligan
Introduction
John Milligan is a notable inventor based in Pittsburgh, PA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of prostate cancer. With a total of two patents to his name, Milligan's work is recognized for its potential impact on medical science.
Latest Patents
Milligan's latest patents focus on small molecule inhibitors of the nuclear translocation of the androgen receptor. These compounds are designed for the treatment of castration-resistant prostate cancer. The patents detail a complex formula that includes various chemical groups and structures, showcasing Milligan's expertise in medicinal chemistry.
Career Highlights
Milligan is affiliated with the University of Pittsburgh, where he conducts research and develops innovative solutions in the pharmaceutical field. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Some of Milligan's notable coworkers include Peter Wipf and James K Johnson. Their collaborative efforts contribute to the innovative research environment at the University of Pittsburgh.
Conclusion
John Milligan's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as a significant inventor. His patents reflect a dedication to advancing medical science and improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile